Follow
Habib Yaribeygi
Title
Cited by
Cited by
Year
The impact of stress on body function: A review
H Yaribeygi, Y Panahi, H Sahraei, TP Johnston, A Sahebkar
EXCLI journal 16, 1057, 2017
14612017
Insulin resistance: Review of the underlying molecular mechanisms
H Yaribeygi, FR Farrokhi, AE Butler, A Sahebkar
Journal of cellular physiology 234 (6), 8152-8161, 2019
7632019
Molecular mechanisms linking oxidative stress and diabetes mellitus
H Yaribeygi, T Sathyapalan, SL Atkin, A Sahebkar
Oxidative medicine and cellular longevity 2020, 2020
5202020
A review of the molecular mechanisms of hyperglycemia‐induced free radical generation leading to oxidative stress
H Yaribeygi, SL Atkin, A Sahebkar
Journal of cellular physiology 234 (2), 1300-1312, 2019
2222019
Sodium–glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
AS H Yaribeygi, AE Butler, SL Atkin, N Katsiki
Journal of Cellular Physiology, 1-8, 2018
131*2018
Sodium–glucose cotransporter inhibitors and oxidative stress: An update
H Yaribeygi, SL Atkin, AE Butler, A Sahebkar
Journal of cellular physiology 234 (4), 3231-3237, 2019
1282019
The underlying role of oxidative stress in neurodegeneration: a mechanistic review
H Yaribeygi, Y Panahi, B Javadi, A Sahebkar
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018
119*2018
Crocin potentiates antioxidant defense system and improves oxidative damage in liver tissue in diabetic rats
H Yaribeygi, MT Mohammadi, A Sahebkar
Biomedicine & Pharmacotherapy 98, 333-337, 2018
1152018
Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
AS H Yaribeygi, Niki Katsiki, Alexandra E. Butler
Drug Discovery Today 2018, 2018
111*2018
Crocin improves renal function by declining Nox‐4, IL‐18, and p53 expression levels in an experimental model of diabetic nephropathy
H Yaribeygi, MT Mohammadi, R Rezaee, A Sahebkar
Journal of cellular biochemistry 119 (7), 6080-6093, 2018
1032018
Interleukin‐18 and diabetic nephropathy: A review
H Yaribeygi, SL Atkin, A Sahebkar
Journal of Cellular Physiology, 2018
992018
Oxidative stress induces renal failure: A review of possible molecular pathways
H Yaribeygi, FR Farrokhi, R Rezaee, A Sahebkar
Journal of cellular biochemistry 119 (4), 2990-2998, 2018
972018
Antioxidative potential of antidiabetic agents: a possible protective mechanism against vascular complications in diabetic patients
H Yaribeygi, AE Butler, GE Barreto, A Sahebkar
Journal of cellular physiology 234 (3), 2436-2446, 2019
902019
Molecular mechanisms by which aerobic exercise induces insulin sensitivity
H Yaribeygi, SL Atkin, LE Simental‐Mendía, A Sahebkar
Journal of cellular physiology 234 (8), 12385-12392, 2019
832019
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment
H Yaribeygi, N Katsiki, B Behnam, H Iranpanah, A Sahebkar
Metabolism 87, 48-55, 2018
752018
Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review
H Yaribeygi, T Sathyapalan, M Maleki, T Jamialahmadi, A Sahebkar
Life sciences 240, 117090, 2020
672020
Antidiabetic potential of saffron and its active constituents
H Yaribeygi, V Zare, AE Butler, GE Barreto, A Sahebkar
Journal of cellular physiology 234 (6), 8610-8617, 2019
672019
Fenofibrate improves renal function by amelioration of NOX‐4, IL‐18, and p53 expression in an experimental model of diabetic nephropathy
H Yaribeygi, MT Mohammadi, R Rezaee, A Sahebkar
Journal of Cellular Biochemistry 119 (9), 7458-7469, 2018
662018
Global Burden of Cardiovascular Diseases and Risks, 1990-2022
GAR GA Mensah, V Fuster, CJL Murray
Journal of the American College of Cardiology 82 (25), 2350-2473, 2023
622023
Mitochondrial dysfunction in diabetes and the regulatory roles of antidiabetic agents on the mitochondrial function
H Yaribeygi, SL Atkin, A Sahebkar
Journal of Cellular Physiology, 2018
612018
The system can't perform the operation now. Try again later.
Articles 1–20